Laparoscopic Reoperative Antireflux Surgery Is More Cost-Effective than Open Approach

Banki, Farzaneh; Weaver, Matt; Roife, David; Kaushik, Chandni; Khanna, Anshu; Ochoa, Kelly; Miller, Charles C.

doi:10.1016/j.jamcollsurg.2017.03.019

Cited by 10 publications

(7 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Surprisingly, the open approach in the present study was associated to better outcomes after RARS, unlike extensive data available [27][28][29][30][31][32][33][34][35] . We believe that this result was attributable to the re-operation rate.…”

contrasting

confidence: 65%

“…In this cohort study of 117 patients, the female/male ratio was 1.54 (71/46), the mean age was 60.4 years (range 17-89 years) and the mean body mass index (BMI) was 25.5 (range [17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35]. As detailed in Table 1, patients were mostly ASA (American Society of Anaesthesiologists classification) II at the time of operation.…”

Section: Patient Characteristicsmentioning

confidence: 99%

See 1 more Smart Citation

Laparoscopic repeat surgery for gastro-oesophageal reflux disease: Results of the analyses of a cohort study of 117 patients from a multicenter experience

Panaro

Leon

Perniceni

et al. 2020

International Journal of Surgery

View full text Add to dashboard Cite

contrasting

confidence: 65%

Section: Patient Characteristicsmentioning

confidence: 99%

Laparoscopic repeat surgery for gastro-oesophageal reflux disease: Results of the analyses of a cohort study of 117 patients from a multicenter experience

Panaro

Leon

Perniceni

et al. 2020

International Journal of Surgery

View full text Add to dashboard Cite

“…Economic studies have noted large savings in the amount of $29,404 per quality life year, indirectly suggesting the advantages of surgical corrections. 6,26 Since the data are from 2010, it is unlikely that the expenses of the robot are accounted for in the calculation. There is still a paucity in direct data.…”

Section: Following-up On a Benign Disease-stopping The Medicationsmentioning

confidence: 99%

“…[1][2][3][4][5] As the learning curve of minimally invasive foregut interventions is surmounted, the rate of complications and costs concurrently decreases as we have seen over the years. [3][4][5][6] Then comes the rise of robotic surgery. The surgical approaches and setup are similar to the laparoscopic methods.…”

Section: Introductionmentioning

confidence: 99%

The Robotic Method of Repairing Dysphagia

Salfity

Hartwig

2020

Innovations�(Phila)

View full text Add to dashboard Cite

“…Health-care systems and individuals incur economic costs for physician visits, medications, and procedures. [28][29][30][31][32][33][34][35] Objective measures such as oesophageal pH monitoring or endoscopy can be used to diagnose gastro-oesophageal reflux disease or its effect on oesophageal mucosa, but these procedures are invasive and can miss cases with fluctuating course. Multiple expert groups have endorsed the use of clinical history and response to therapy in making a clinical diagnosis.…”

Section: Introductionmentioning

confidence: 99%

The global, regional, and national burden of gastro-oesophageal reflux disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Dirac¹,

Safiri²,

Tsoi³

et al. 2020

The Lancet Gastroenterology & Hepatology

View full text Add to dashboard Cite

Background Gastro-oesophageal reflux disease is a common chronic ailment that causes uncomfortable symptoms and increases the risk of oesophageal adenocarcinoma. We aimed to report the burden of gastro-oesophageal reflux disease in 195 countries and territories between 1990 and 2017, using data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017. Methods We did a systematic review to identify measurements of the prevalence of gastro-oesophageal reflux disease in geographically defined populations worldwide between 1990 and 2017. These estimates were analysed with DisMod-MR, a Bayesian mixed-effects meta-regression tool that incorporates predictive covariates and adjustments for differences in study design in a geographical cascade of models. Fitted values for broader geographical units inform prior distributions for finer geographical units. Prevalence was estimated for 195 countries and territories. Reports of the frequency and severity of symptoms among individuals with gastrooesophageal reflux disease were used to estimate the prevalence of cases with no, mild to moderate, or severe to very severe symptoms at a given time; these estimates were multiplied by disability weights to estimate years lived with disability (YLD). Findings Data to estimate gastro-oesophageal reflux disease burden were scant, totalling 144 location-years (unique measurements from a year and location, regardless of whether a study reported them alongside measurements for other locations or years) of prevalence data. These came from six (86%) of seven GBD super-regions, 11 (52%) of 21 GBD regions, and 39 (20%) of 195 countries and territories. Mean estimates of age-standardised prevalence for all locations in 2017 ranged from 4408 cases per 100 000 population to 14 035 cases per 100 000 population. Agestandardised prevalence was highest (>11 000 cases per 100 000 population) in the USA, Italy, Greece, New Zealand, and several countries in Latin America and the Caribbean, north Africa and the Middle East, and eastern Europe; it was lowest (<7000 cases per 100 000 population) in the high-income Asia Pacific, east Asia, Iceland, France, Denmark, and Switzerland. Global prevalence peaked at ages 75-79 years, at 18 820 (95% uncertainty interval [95% UI] 13 770-24 000) cases per 100 000 population. Global age-standardised prevalence was stable between 1990 and 2017 (8791 [95% UI 7772-9834] cases per 100 000 population in 1990 and 8819 [7781-9863] cases per 100 000 population in 2017, percentage change 0•3% [-0•3 to 0•9]), but all-age prevalence increased by 18

show abstract

Laparoscopic Reoperative Antireflux Surgery Is More Cost-Effective than Open Approach

Cited by 10 publications

References 23 publications

Laparoscopic repeat surgery for gastro-oesophageal reflux disease: Results of the analyses of a cohort study of 117 patients from a multicenter experience

Laparoscopic repeat surgery for gastro-oesophageal reflux disease: Results of the analyses of a cohort study of 117 patients from a multicenter experience

The Robotic Method of Repairing Dysphagia

The global, regional, and national burden of gastro-oesophageal reflux disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Contact Info

Product

Resources

About